cervical dysplasia


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

cer·vi·cal dys·pla·si·a

dysplasia of the uterine cervix, epithelial atypia involving part or all of the thickness of cervical squamous epithelium, occurring most often in young women; appears to regress frequently, but may progress over a long period to carcinoma; severe dysplasia may be microscopically indistinguishable from carcinoma in situ.

cervical dysplasia

Cervical intraepithelial neoplasia–CIN, see there.

Cervical dysplasia

Dysplasia is the abnormal growth of the epithelial cells. This is what a Pap smear will detect in the cervix.
Mentioned in: Pelvic Exam
References in periodicals archive ?
[ClickPress, Fri Apr 19 2013] Global Markets Direct's, 'Cervical Dysplasia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.
at the University of North Carolina, Chapel Hill, and is director of the North Carolina Women's Hospital Cervical Dysplasia Clinic.
vaginalis and Candidiasis with cervical dysplasia in symptomatic Indian women.
(3) Therefore, colposcopy is also indicated for patients with symptoms suggestive of cervical dysplasia or cancer (abnormal appearance of the cervix, or persistent and undiagnosed vaginal discharge or bleeding), even in the setting of normal cytology.
* Because of the potential for adverse obstetric complications following excisional procedures for cervical dysplasia, gynecologists should closely adhere to the American Society for Colposcopy and Cervical Pathology guidelines when determining the appropriateness of dysplasia interventions.
The inclusion criteria were 20 to 60 years of age, HPV positive, no evidence of high-grade squamous intraepithelial lesions (HSIL) by Pap smear and colposcopy, no previous history of cervical dysplasia or cancer, not pregnant, and HIV negative.
M2 EQUITYBITES-May 1, 2012-Inovio Pharmaceuticals Inc receives US patent protection for synthetic vaccine for cervical dysplasia and cancer(C)2012 M2 COMMUNICATIONS http://www.m2.com
M2 PHARMA-October 22, 2010-Advaxis completes recruitment of first patient group in US cervical dysplasia study(C)2010 M2 COMMUNICATIONS
Overall, CIN 2,3 was present in 35% of adolescent patients referred to colposcopy for cervical dysplasia.
"Forty percent didn't come back for their second smear, which is a very high rate of non-compliance, and this is one of the factors that puts this group at high risk for cervical dysplasia," she said.
* Further studies are needed to determine the most effective treatment for mild cervical dysplasia and possible local effects of cryotherapy.
announced the initiation and opening of sites to enroll the second portion of the company's Phase 3 program for VGX-3100, Inovio's DNA-based immunotherapy to treat cervical dysplasia caused by human papillomavirus (HPV).